Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
HanAll Biopharma Reports First Quarter Results and Provides Business Update 2023-04-28 19:00
WuXi Biologics Releases 2022 ESG Report Detailing Its Continued Commitment to Sustainability 2023-04-28 14:43
Daewoong Pharmaceutical announces a Global License Agreement for DWP213388, a new drug candidate for autoimmune disease with Vitalli Bio 2023-04-28 08:58
ASCO 2023 | Ascentage Pharma to Present Results from 4 Studies Highlighting Extended Therapeutic Potential of Lead Drug Candidates 2023-04-27 17:44
Gracell Biotechnologies to Present Updated Clinical Data on BCMA/CD19 Dual-Targeting FasTCAR-T GC012F at 2023 ASCO Annual Meeting 2023-04-26 22:15
I-Mab Announces Poster Presentation of Proprietary CD73 Antibody Uliledlimab at ASCO 2023 2023-04-26 21:16
J INTS BIO, AACR 2023 - Presentation of preclinical study results of 'JIN-A04', an oral target therapy for HER2 exon insertion mutation NSCLC 2023-04-26 09:53
BIORCHESTRA Scientific Founder, Chairman, and Chief Executive Officer Joins the Republic of Korea (ROK) Official State Visit to the United States 2023-04-25 20:00
I-Mab Announces Positive Outcome in Arbitration Relating to Agreements with Tracon 2023-04-25 13:46
Ascentage Pharma Passes GMP Compliance Audit by EU QP with Zero Deficiency, in an Achievement Signaling Global Recognition of the Company's Quality Management System 2023-04-25 08:42
A new super factory with 29 GMP grade production lines for gene and cell therapy was launched in Shanghai by OBiO technology 2023-04-24 22:36
WuXi AppTec Continued Solid Growth in First-Quarter of 2023 On Top of an Exceptionally Strong Year of 2022 2023-04-24 18:03
Samsung Biologics Reports First Quarter 2023 Financial Results 2023-04-24 14:51
Bridge Biotherapeutics Receives FDA Authorization to Proceed with the First-in-Human Study of BBT-207, a 4th generation EGFR TKI 2023-04-24 10:00
ITRI Took Home Three Edison Awards(TM) in 2023 2023-04-21 19:27
ImmVira Appoints Dr. Oliver Kong as Chief Medical Officer 2023-04-21 09:06
CARsgen's CAR T-cell Candidate CT041 Achieves IND Clearance from the NMPA for the Postoperative Adjuvant Therapy of Pancreatic Cancer 2023-04-20 20:50
CBC GROUP AND MUBADALA CO-LEAD US$315 MILLION FUNDRAISING ROUND FOR HASTEN BIOPHARMA 2023-04-20 13:00
Innovent Announces Overall Survival Results of Phase 2 Study of Pemazyre® (pemigatinib) in Chinese Patients with Advanced Cholangiocarcinoma Presented at AACR Annual Meeting 2023 2023-04-20 08:00
Nona Biosciences and Washington University Join Forces to Tackle Emerging RNA Viruses 2023-04-19 08:45
1 54 55 56 57 58 222